LOTT 10-K & 10-Q changes, risk factors and insider trading
Techlott Inc. · OTC · Services-Computer Programming Services · CIK 1568969 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “The audited consolidated financial statements included in this Annual Report have been prepared assuming the Company will continue as a going concern.”
New heading “Our unprecedented transformation from sleep apnea technology to lottery and gaming technology lacks any operational track record and may completely fail.”
New heading “Our Senior Management has certain contractual anti-dilution protection which are intended to protect their aggregate holdings of 70% of our company.”
New heading “Our Chief Executive Officer’s commitments to other companies may limit his ability to devote full-time attention to our business and could result in competition or conflicts of interest, which could adversely affect our operations and financial performance.”
New heading “If we do not effectively manage our growth and the associated demands on our operational, risk management, sales and marketing, technology, compliance and finance and accounting resources, our business may be adversely impacted.”
New heading “We are subject to heightened operational and cybersecurity risks.”
New heading “We rely on third parties in critical aspects of our business, which creates additional risk. Our ability to offer our services depends on relationships with other financial services institutions and entities, and our inability to maintain existing relationships or to enter into new such relationships could impact our ability to offer services to customers.”
New heading “Competition within the global sports, entertainment and gaming industries is intense and if we fail to compete effectively, our users may be attracted to our competitors or to competing forms of entertainment including those on mobile devices and web applications, such as streaming, online gaming, esports, and online sports betting. If our offerings are not popular, we could experience price reductions, reduced margins, loss of market share, and our business, financial condition, and results of operations could be harmed.”
New heading “Economic downturns, inflation, and political and market conditions beyond our control could adversely affect our business, financial condition, and results of operations.”
New heading “Negative events or negative media coverage relating to, or a declining popularity of, the lottery or lottery games in general, or other negative coverage relating to lottery, forms of online gaming or betting, or the gaming industry, may adversely impact our ability to retain or attract users, which could have an adverse impact on our business, financial condition, and results of operations.”
New heading “We are subject to risks related to corporate social responsibility, responsible gaming, reputation, and ethical conduct.”
New heading “Risks Related to Our Digital Health Business”
New heading “Our subsidiary, SleepX Ltd. and B.G. Negev Technologies and Applications Ltd., and Mor Research Application Ltd., have entered into a Licensing agreement which if terminated could have adverse effects on our digital health business.”
New heading “Escalating global conflicts, particularly the ongoing wars in the Middle East and Ukraine, create both heightened demand and severe operational risks for our business.”
Removed heading “We have generated to date an insignificant amount of revenue from commercial sales to date and our future profitability is uncertain.”
Removed heading “There is substantial doubt about our ability to continue as a going concern.”
Removed heading “Risks Relating to our Business and our Industry”
Removed heading “Certain of our Convertible Note Holders have a security interest on all our assets securing the advances made to us”
Removed heading “Our subsidiary, SleepX Ltd. and B.G. Negev Technologies and Applications Ltd., and Mor Research Application Ltd., have entered into a Licensing agreement which if terminated could have adverse effects on our business.”
Removed heading “The market opportunity for our products and services may not develop in the ways that we anticipate.”
Removed heading “Our ability to implement and manage growth strategy is uncertain.”
Removed heading “Since our products may be available over the Internet in foreign countries and the Company may have customers residing in foreign countries, foreign jurisdictions may require it to qualify to do business in their country. It will be required to comply with certain laws and regulations of each country in which it conducts business, including laws and regulations currently in place or which may be enacted related to Internet services available to the residents of each country from online sites located elsewhere.”
Removed heading “We intend to rely on third parties to conduct clinical trials (if needed). If these third parties do not meet our deadlines or otherwise conduct the trials as required, our clinical trials programs could be delayed or unsuccessful and we may not be able to obtain regulatory approval for or commercialize our product candidates when expected or at all.”
Removed heading “Government Regulations May Result in Costs and Delays.”
Removed heading “Any product candidates we may advance into clinical trials (assuming the FDA so requires) may be subject to extensive regulation, which can be costly and time consuming, cause unanticipated delays or prevent the receipt of the required approvals to commercialize some of our product candidates, all of which can adversely affect our business.”
Removed heading “We may be subject to numerous and varying privacy and security laws, and our failure to comply could result in penalties and reputational damage.”
Removed heading “If we or our third-party manufacturers fail to comply with the FDA’s Quality System Regulation, or QSR, our manufacturing operations could be interrupted.”
Removed heading “We depend on our collaborators to help us develop and test our devices, and our ability to develop and commercialize our devices may be impaired or delayed if collaborations are unsuccessful.”
Removed heading “We may not develop a substantial number of commercialized products.”
Removed heading “Non-FDA Government Regulation May Affect our Results.”
Removed heading “Our Clinical Trials could be delayed by factors over which we have little control.”
Removed heading “The FDA may require additional Clinical Trials and any adverse results in such Clinical Trials, or difficulties in conducting such Clinical Trials, could have a material adverse effect on our business.”
Removed heading “If any additional products are approved by the FDA, they may be approved only for narrow indications.”
Removed heading “Our reliance on the activities of our non-employee consultants whose activities are not wholly within our control, may lead to delays in development of proposed products or in the development of our business.”
Removed heading “Our technology development is headquartered in Israel and, therefore, our results may be adversely affected by economic restrictions imposed on, and political and military instability in, Israel.”
Removed heading “Our operations and the operations of our contract manufacturer may be disrupted as a result of the obligation of Israeli citizens to perform military service.”
Removed heading “Our sales may be adversely affected by boycotts of Israel.”
Largest changes
“In addition, changes in general market, economic, and political conditions in domestic and foreign economies or financial markets, including those resulting from, for example: the ongoing effects of the COVID-19 pandemic; rising interest rates and inflation; geopolitical challenges, including global security concerns in response to Russia’s continued war in Ukraine and regional wars in the Middle East; financial and credit market instability or the unavailability of credit; and fluctuation in stock markets, may reduce users’, customers’, or subscribers’ disposable income and corporate budgets. …”see in full comparison
“We are subject to laws and regulations covering data privacy and the protection of personal information, including health information. The legislative and regulatory landscape for privacy and data protection continues to evolve, and there has been an increasing focus on privacy and data protection issues which may affect our business. …”see in full comparison
“Our financial performance is subject to global economic conditions and their impact on levels of spending by potential users and customers of our Platform a. Economic recessions, or other economic conditions such as rising inflation and interest rates, have had, and may continue to have, far reaching adverse consequences across many industries, including the global entertainment, lottery, sweepstakes and promotions, and gaming industries, which may adversely affect our business, financial condition, and results of operations. Tepid growth was experienced in the U.S. …”see in full comparison
“There is substantial doubt about our ability to continue as a going concern.”see in full comparison
“Escalating global conflicts, particularly the ongoing wars in the Middle East and Ukraine, create both heightened demand and severe operational risks for our business.”see in full comparison
“The global security environment has deteriorated significantly, with active military conflicts in the Middle East (including the ongoing conflict in Israel and the broader regional tensions involving Iran, Hezbollah, and other actors) and the continuing war in Ukraine now entering its fourth year. While these conflicts may drive increased defense spending globally, they create severe and direct operational risks for our company. …”see in full comparison
Full comparison: every changed paragraph (111)
Risk Related to our Lottery and Gaming business, Financial Position and Need for Capital
The audited consolidated financial statements included in this Annual Report have been prepared assuming the Company will continue as a going concern.
The Company recorded negative working capital of approximately $0.22 million and stockholders’ surplus of $12.9 million as of December 31, 2025; a net operating loss of $15.1 million and net cash used in operations of $0.6 million for the year ended December 31, 2025. Absent any other action, the Company will require additional liquidity to continue its operations for the next 12 months.
Our unprecedented transformation from sleep apnea technology to lottery and gaming technology lacks any operational track record and may completely fail.
The lottery and gaming industry operates under fundamentally different business models, regulations, and customer requirements than financial services. There is no assurance that we will successfully execute this transformation or generate any returns from the substantial capital being deployed. Our complete lack of defense industry track record means investors are funding an entirely unproven strategy that may result in total loss of invested capital.
We
have generated to date an insignificant amount of revenue from commercial sales to date and our future profitability is uncertain.
We
are incorporated in Nevada and have a limited operating history, and our business is subject to all of the risks inherent in the establishment
of a new business enterprise. Our likelihood of success must be considered in light of the problems, expenses, difficulties, complications
and delays frequently encountered in connection with development and expansion of a new business enterprise. Since inception, we have
incurred losses and expect to continue to operate at a net loss for at least the next year. Our net losses for the years ended December
31, 2023 and December 31, 2024, were $1,817,000 and $4,032,000, respectively, and our accumulated deficit as of December 31, 2023 and
December 31, 2024 was $6,326,000 and $10,358,000, respectively. There can be no assurance that the products will be successfully commercialized,
and the extent of our future losses and the timing of our profitability are highly uncertain. If we are unable to achieve profitability,
we may be unable to continue our operations.
Our Senior Management has certain contractual anti-dilution protection which are intended to protect their aggregate holdings of 70% of our company.
Our Senior Management has certain contractual anti-dilution protection that provide them broad anti-dilution protection for up to $10 million of value recorded in the Company. These persons hold, in the aggregate approximately 70% of our company. Their anti-dilution protection is not limited to solely additional capital raises but covers all issuances to third parties for any value recorded in the Company’s books such mergers and acquisitions, licensing, etc.
Unless waived by the holders, these anti-dilution provisions may inhibit or impair our ability to raise capital as needed. Failure to raise capital when needed can result in significant harm to our business.
Our Chief Executive Officer’s commitments to other companies may limit his ability to devote full-time attention to our business and could result in competition or conflicts of interest, which could adversely affect our operations and financial performance.
Yakir Abadi our Chief Executive Officer, also maintains and oversees other business ventures. These roles require Mr. Abadi to devote significant time and resources to the management and strategic direction of these other companies, which may reduce the time and attention he can dedicate to our company. This divided focus could impair our ability to execute our business strategy, particularly as we transition to a lottery and gaming company. The competing demands on Mr. Abadi’s time may delay critical decision-making, hinder our ability to respond to market opportunities, or weaken our operational oversight, all of which could materially adversely affect our business, financial condition, and results of operations.
Furthermore, certain of the businesses interest of Mr. Abadi may operate in sectors or pursue opportunities that compete with our current or future operations. Mr. Abadi’s involvement in these companies could lead to conflicts of interest, including the allocation of business opportunities, resources, or strategic priorities that may favor these other entities over our company. Any such competition or conflicts could harm our competitive position, limit our growth prospects, and negatively impact the value of our securities.
We are particularly reliant on the services of our Chief Executive Officer, President and Chief Technology Officer. A loss of any one of them or one or more of our current officers or key employees or consultants could severely and negatively impact our operations. We have no present intention of obtaining key-man life insurance on any of our executive officers or management. Additionally, competition for highly skilled technical, managerial and other personnel is intense. As our business develops, we might not be able to attract, hire, train, retain and motivate the highly skilled managers and employees we need to be successful. If we fail to attract and retain the necessary technical and managerial personnel, our business will suffer and might fail.
If we do not effectively manage our growth and the associated demands on our operational, risk management, sales and marketing, technology, compliance and finance and accounting resources, our business may be adversely impacted.
To effectively manage and capitalize on our growth, we must continue to expand our information technology and financial, operating, and administrative systems and controls, and continue to manage headcount, capital, and processes efficiently. Our continued growth could strain our existing resources, and we could experience ongoing operating difficulties in managing our business as it expands, including difficulties in hiring, training, and managing an employee base. Failure to scale could harm our future success, including our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives. If we do not adapt to meet these evolving challenges, or if our management team does not effectively scale with our growth, we may experience erosion to our reputation and the integration of our products and services. Moreover, the failure of our systems and processes could undermine our ability to provide accurate, timely, and reliable reports on our financial and operating results, including the financial statements provided herein, and could impact the effectiveness of our internal controls over financial reporting. In addition, our systems and processes may not prevent or detect all errors, omissions, or fraud, though we have experienced no such material errors, omissions or fraud in the past. Any of the foregoing operational failures could lead to noncompliance with laws, loss of revenues, licenses or other government authorizations, or loss of relationships that could substantially impair or even suspend company operations.
The future growth of our business depends on its ability to retain existing customers, attract new customers as well as getting existing customers and new customers to increase the volumes processed through our payments platform and therefore grow revenue. Our customers are not subject to any minimum volume commitments and they have no obligation to continue to use our services, and we cannot be sure that customers will continue to use our services or that we will be able to continue to attract new volumes at the same rate as we have in the past.
A customer’s use of our services may decrease for a variety of reasons, including the customer’s level of satisfaction with our products and services, the expansion of business to offer new products and services, the effectiveness of our support services, the pricing of our products and services, the pricing, range and quality of competing products or services, the effects of global economic conditions, regulatory or financial institution limitations, trust, perception and interest in foreign exchange and payment processing services and in our products and services, or reductions in the customer’s payment and transfer activity. Furthermore, the complexity and costs associated with switching to a competitor may not be significant enough to prevent a customer from switching service providers, especially for larger customers who commonly engage more than one payment service provider at any one time.
Any failure by us to retain existing customers, attract new customers, and increase revenue from both new and existing customers could materially and adversely affect our business, financial condition, results of operations and prospects. These efforts may require substantial financial expenditures, commitments of resources, developments of our processes, and other investments and innovations.
We are subject to heightened operational and cybersecurity risks.
We are subject to heightened operational and cybersecurity risks. Many of our employees work from their homes or other non-company dwellings. Technologies in our employees’ and service providers’ homes and shared office spaces may not be as robust and could cause the networks, information systems, applications, and other tools available to employees and service providers to be more limited or less reliable. Further, the security systems in place at our employees’ and service providers’ homes and shared office spaces may be less secure than those used in corporate offices, and while we have implemented technical and administrative safeguards to help protect our systems when our employees and service providers work from home, we may be subject to increased cybersecurity risk which could expose us to risks of data or financial loss, and could disrupt our business operations. There is no guarantee that the data security and privacy safeguards we have put in place will be completely effective or that we will not encounter risks associated with employees and service providers accessing company data and systems remotely.
We rely on third parties in critical aspects of our business, which creates additional risk. Our ability to offer our services depends on relationships with other financial services institutions and entities, and our inability to maintain existing relationships or to enter into new such relationships could impact our ability to offer services to customers.
As we build our lottery and gaming business, we will depend on relationships with specialized subcontractors, and government-approved suppliers. We will depend on various third-party partners including prime contractors.
Also, critical aspects of our technology will rely on third-party technologies. Our lack of established relationships in the industry and foreign ownership structure may be an impediment to our ability to establish partnerships with major defense contractors. Should potential partners refuse to work with us, we would be at risk of being unable to participate in major defense programs.
Third parties upon which we rely on may refuse to partner with us, may breach their agreements with us, refuse to enter into agreements on commercially reasonable terms, take actions that degrade the functionality of our services, impose additional costs or requirements on us, or give preferential treatment to established defense contractors, any of which could prevent us from competing effectively and materially and adversely affect our business, financial condition, results of operations and prospects.
Some third parties that provide services to our industry may have significant market power and be able to impose unfavorable terms on new entrants like us. In addition, there can be no assurance that third parties will be willing to work with us on acceptable terms, or at all. If we cannot establish necessary partnerships, we may be unable to compete for defense contracts, which may materially and adversely affect our business, financial condition, results of operations and prospects.
Competition within the global sports, entertainment and gaming industries is intense and if we fail to compete effectively, our users may be attracted to our competitors or to competing forms of entertainment including those on mobile devices and web applications, such as streaming, online gaming, esports, and online sports betting. If our offerings are not popular, we could experience price reductions, reduced margins, loss of market share, and our business, financial condition, and results of operations could be harmed.
Our users have a vast array of entertainment choices, including television, movies, sporting events, in-person lottery gaming, real money gaming, and sports betting, all of which are more established and may be perceived by our users to offer greater variety, affordability, interactivity, and enjoyment than our offerings. We compete with these and other forms of entertainment for our users’ discretionary time and income. If we are unable to sustain sufficient interest in our product offerings in comparison to other forms of entertainment, including new and emerging forms of entertainment available on mobile devices and web applications, such as streaming, online gaming, esports, and online sports betting, our business model may not continue to be viable.
In addition, the specific industries in which we have historically operated are characterized by dynamic consumer demand and technological advances, and there is intense competition amongst providers to the lottery, online gaming, sports betting, and promotions industries. Specifically, a number of established, well-financed third-party lottery application companies, online gaming providers, sports betting, and interactive entertainment companies have competed with our offerings, and other well-capitalized companies may introduce competitive services that achieve greater market acceptance. Such competitors may spend more money and time on developing and testing products, services, and systems, undertake more extensive marketing campaigns, adopt more aggressive pricing or promotional policies, or otherwise develop more commercially successful products, services, or systems than we are able, which could negatively impact our business. Furthermore, new competitors may enter the mobile lottery industry, and government lottery operators may introduce forms of online lottery gaming that compete with our services. There has also been, and continues to be, considerable consolidation among competitors in the entertainment, gaming, and lottery industries, and such consolidation, and future consolidation, could result in the formation of larger competitors with increased financial resources and altered cost structures, which may enable them to offer more competitive products, gain a larger market share, expand offerings, and broaden their geographic scope of operations. If we are not able to achieve some market share, if our offerings are not popular, or if we are not able to provide competitive products, our business, financial condition, and results of operations could be harmed.
Economic downturns, inflation, and political and market conditions beyond our control could adversely affect our business, financial condition, and results of operations.
Our financial performance is subject to global economic conditions and their impact on levels of spending by potential users and customers of our Platform a. Economic recessions, or other economic conditions such as rising inflation and interest rates, have had, and may continue to have, far reaching adverse consequences across many industries, including the global entertainment, lottery, sweepstakes and promotions, and gaming industries, which may adversely affect our business, financial condition, and results of operations. Tepid growth was experienced in the U.S. and globally following the financial crisis in 2008 through 2009, and there may be an increasing risk of a recession or inflationary economic impacts due to international trade and monetary policy, rising interest rates and inflation, and acts or threats of acts of war (including the ongoing war in the Ukraine and Middle East), along with other economic challenges. If the national and international economic recovery slows or stalls, these economies experience another recession, or any of the relevant regional or local economies suffers a downturn, or if inflationary effects accelerate, we may experience a material adverse effect on our business, financial condition, or results of operations.
In addition, changes in general market, economic, and political conditions in domestic and foreign economies or financial markets, including those resulting from, for example: the ongoing effects of the COVID-19 pandemic; rising interest rates and inflation; geopolitical challenges, including global security concerns in response to Russia’s continued war in Ukraine and regional wars in the Middle East; financial and credit market instability or the unavailability of credit; and fluctuation in stock markets, may reduce users’, customers’, or subscribers’ disposable income and corporate budgets. Any one of these changes could have a material adverse effect on our business, financial condition, or results of operations and could cause the value of our securities to decline or become worthless.
Negative events or negative media coverage relating to, or a declining popularity of, the lottery or lottery games in general, or other negative coverage relating to lottery, forms of online gaming or betting, or the gaming industry, may adversely impact our ability to retain or attract users, which could have an adverse impact on our business, financial condition, and results of operations.
Public opinion can significantly influence our business. Unfavorable publicity regarding, for example, our company, members of our management and Board, our technology, our implementation of upgrades and changes to our technology, the quality of our Platform and its interfaces, our product offerings, our other services and systems, actual or threatened litigation or regulatory activity, the actions of third parties with whom we have relationships, our ability to recommence our business operations, or the conduct of the lottery authorities and the products they offer, including declining popularity of a particular lottery game or lottery games in general, could seriously harm our reputation. In addition, a negative shift in the perception of lottery games by the public or by politicians, lobbyists, or others could affect future legislation regarding the mobile purchase of lottery games from third-party providers, including with respect to the regulation or licensure of couriers, or with respect to the legalization of online lottery game sales (“Online Lottery”), either of which may impact our operations. Negative public perception could also lead to new restrictions on or to the prohibition of mobile lottery play in jurisdictions in which we currently operate. Such negative publicity could also adversely affect the size, demographics, engagement, and loyalty of our new players and established user base, and it could result in decreased revenue or slower user growth rates, which could seriously harm our business, financial condition, and results of operations and could cause the value of our securities to decline or become worthless.
We are subject to risks related to corporate social responsibility, responsible gaming, reputation, and ethical conduct.
Many factors influence our reputation and the value of our brands, including the perception held by our users, customers, business partners, investors, regulatory authorities, key stakeholders, and the communities in which we operate, such as our social responsibility, corporate governance, and responsible gaming practices. We have faced, and will likely continue to face, increased scrutiny related to social, governance and responsible gaming activities, and our reputation and the value of our brands can be materially adversely harmed if we fail to act responsibly in a number of areas, such as diversity and inclusion, workplace conduct, responsible gaming, human rights, philanthropy, and support for local communities. Any harm to our reputation could impact employee engagement and retention, and the willingness of users, customers and partners to do business with us, which could have a materially adverse effect on our business, financial condition, and results of operations and could cause the value of our securities to decline or become worthless.
Illegal, unethical or fraudulent activities perpetrated by any of our members of management or Board, users, customers, or partners for personal gain could expose us to potential reputational damage and financial loss, which would negatively impact our business, financial condition, and results of operations and could cause the value of our securities to decline or become worthless.
There
is substantial doubt about our ability to continue as a going concern.
As
of December 31, 2024, we had cash of $79,000. In addition, as of December 31, 2024, we had liabilities of $4,527,000. As of the date
of this report, we do not have adequate resources to fund our operations through August 2024 without considering any potential future
milestone payments that we may receive under any new collaborations that we may enter into in the future or any future capital raising
transactions. We do not know whether additional financing will be available when needed, whether it will be available on favorable terms,
or if it will be available at all. These factors raise substantial doubt about our ability to continue as a going concern. In the event
that we are unable to obtain additional financing, we may be unable to continue as a going concern. There is no guarantee that we will
be able to secure additional financing. Changes in our operating plans, our existing and anticipated working capital needs, costs related
to legal proceedings we might become subject to in the future, the acceleration or modification of our development activities, any near-term
or future expansion plans, increased expenses, potential acquisitions or other events may further affect our ability to continue as a
going concern.
Similarly,
the report of our independent registered public accounting firm on our financial statements as of and for the year ended December 31,
2024 includes an explanatory paragraph indicating that there is substantial doubt about our ability to continue as a going concern. If
we cannot continue as a viable entity, our stockholders may lose some or all of their investment in us.
Risks
Relating to our Business and our Industry
Certain
of our Convertible Note Holders have a security interest on all our assets securing the advances made to us
In
connection with the funding transaction we entered into with Leonite Capital LLC in November 2021, between November 2021 and May
9, 2022 Leonite advanced to us a loan $500,000 with an original issue discount of $88,235.29, and the total outstanding principal amount
is $588,235.29. all of our obligation under the Leonite note were secured by a floating lien on all of our assets.
On
July 3, 2023, the outstanding Leonite note was purchased by third parties. Accordingly these parties currently hold such security interest
in our assets. If however we are unable to repay those investors for whatever reason or do not satisfy the loan, such non-repayment would
constitute an event of default under the agreement with these note holders. Any event of default can lead to a material adverse effect
on our business.
Our
subsidiary, SleepX Ltd. and B.G. Negev Technologies and Applications Ltd., and Mor Research Application Ltd., have entered into a Licensing
agreement which if terminated could have adverse effects on our business.
The
market opportunity for our products and services may not develop in the ways that we anticipate.
The
demand for our products and services can change quickly and in ways that we may not anticipate because the market in which we operate
is characterized by rapid, and sometimes disruptive, technological developments, evolving industry standards, frequent new product introductions
and enhancements, changes in customer requirements and a limited ability to accurately forecast future customer orders. Our operating
results may be adversely affected if the market opportunity for our products and services does not develop in the ways that we anticipate
or if other technologies become more accepted or standard in our industry or disrupt our technology platforms.
A
loss of one or more of our current officers or key employees or consultants could severely and negatively impact our operations. We have
no present intention of obtaining key-man life insurance on any of our executive officers or management. Additionally, competition for
highly skilled technical, managerial and other personnel is intense. As our business develops, we might not be able to attract, hire,
train, retain and motivate the highly skilled managers and employees we need to be successful. If we fail to attract and retain the necessary
technical and managerial personnel, our business will suffer and might fail.
Our
ability to implement and manage growth strategy is uncertain.
Implementation
of our growth strategy may impose significant strain on our management, operating systems and financial resources. Failure by the Company
to manage its growth, or unexpected difficulties encountered during expansion into different markets, could have a materially adverse
impact on our results of operations or financial condition. Our ability to continue to operate our business depends upon a number of
factors, including (i) generating sufficient funds for operations, (ii) our executive management team and our financial and accounting
controls, and (iii) staffing, training and retaining skilled on-site management personnel. Certain of these factors are beyond our control
and may be affected by the economy or actions taken by competing companies. Further, there can be no assurance that our market analysis
and proprietary business data will continue to support our current marketing plans.
Since
our products may be available over the Internet in foreign countries and the Company may have customers residing in foreign countries,
foreign jurisdictions may require it to qualify to do business in their country. It will be required to comply with certain laws and
regulations of each country in which it conducts business, including laws and regulations currently in place or which may be enacted
related to Internet services available to the residents of each country from online sites located elsewhere.
The
Company’s operations in developing markets could expose it to political, economic and regulatory risks that are greater than those
it may face in established markets. Further, its international operations may require it to comply with additional United States and
international regulations.
For
example, it may be required to comply with the Foreign Corrupt Practices Act, or “FCPA,” which prohibits companies or their
agents and employees from providing anything of value to a foreign official or agent thereof for the purposes of influencing any act
or decision of these individuals in their official capacity to help obtain or retain business, direct business to any person or corporate
entity or obtain any unfair advantage. The Company may operate in some nations that have experienced significant levels of governmental
corruption. Its employees, agents and contractors, including companies to which it outsources business operations, may take actions in
violation of its policies and legal requirements. Such violations, even if prohibited by its policies and procedures, could have an adverse
effect on its business and reputation. Any failure by the Company to ensure that its employees and agents comply with the FCPA and applicable
laws and regulations in foreign jurisdictions could result in substantial civil and criminal penalties or restrictions on its ability
to conduct business in certain foreign jurisdictions, and its results of operations and financial condition could be materially and adversely
affected.
Risks Related to Our Digital Health Business
Our subsidiary, SleepX Ltd. and B.G. Negev Technologies and Applications Ltd., and Mor Research Application Ltd., have entered into a Licensing agreement which if terminated could have adverse effects on our digital health business.
We
intend to rely on third parties to conduct clinical trials (if needed). If these third parties do not meet our deadlines or otherwise
conduct the trials as required, our clinical trials programs could be delayed or unsuccessful and we may not be able to obtain regulatory
approval for or commercialize our product candidates when expected or at all.
We
do not have the ability to conduct all aspects of our clinical trials ourselves. We intend to use Contract Research Organizations (CROs)
to conduct clinical trials that we may be required to conduct and will rely upon medical institutions, clinical investigators and CRO’s
and consultants to conduct these trials in accordance with our clinical protocols. Our future CROs, investigators and other third parties
play a significant role in the conduct of these trials and the subsequent collection and analysis of data from the clinical trials.
There
is no guarantee that any CROs, investigators and other third parties upon which we rely for administration and conduct of clinical trials
will devote adequate time and resources to such trials or perform as contractually required. If any of these third parties fail to meet
expected deadlines, fail to adhere to our clinical protocols or otherwise perform in a substandard manner, our clinical trials may be
extended, delayed, or terminated. If any of these clinical trial sites terminate for any reason, we may experience the loss of follow-up
information on patients enrolled in our ongoing clinical trials unless we are able to transfer the care of those patients to another
qualified clinical trial site. In addition, principal investigators for any clinical trials we conduct may serve as scientific advisors
or consultants to us from time to time and receive cash or equity compensation in connection with such services. If these relationships
and any related compensation result in perceived or actual conflicts of interest, the integrity of the data generated at the applicable
clinical trial site may be jeopardized.
Government
Regulations May Result in Costs and Delays.
The
development, testing, production and marketing of our future products are subject to regulation by the FDA as devices under 1976 Medical
Device Amendments to the Federal Food, Drug and Cosmetic Act. Additionally, our products may be subject to regulation by similar agencies
in other states and foreign countries. While we believe that we have complied with all applicable laws and regulations, continued compliance
with such laws or regulations, including any new laws or regulations, might impose additional costs on us which could adversely affect
its financial performance and results of operations.
Management's Discussion & Analysis (MD&A)
New heading “Significant Events that Occurred During 2025”
Largest changes
“Our accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these consolidated financial statements. However, the Company has incurred substantial losses. Our current liabilities exceed our current assets and available cash is not sufficient to fund the expected future operations. …”see in full comparison
“In addition, the Company capitalizes qualifying costs incurred during the application development stage related to software developed for internal use. These costs are capitalized based on qualifying criteria. Costs incurred to develop software applications consist of directly attributable costs of preparing the asset for its intended use such as direct labor costs, direct consultants and subcontractors costs, and overhead. Testing of impairment is performed annually over the period of the development project. …”see in full comparison
“Certain of the Company’s employees have subscribed to Section 14 of Israel’s Severance Pay Law, 5723-1963 (“Section 14”). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section 14 release the Company from any future severance liabilities (under the above Israeli Severance Pay Law) in respect of those employees. Neither severance pay liability nor severance pay fund under Section 14 is recorded on the Company’s balance sheet.”see in full comparison
“(vi) On September 30, 2025, the Board e agreed to change the aforementioned resolution regarding the issuance of such options to Mr. Abadi and Mr. Grady, and instead, to enter into a subscription agreement for an identical number of shares of the company’s common stocks at a per share purchase price of $0.0001. see Item (xi) below. The Subscription Agreement goes into effect upon the increase in the Company’s authorized share capital. …”see in full comparison
“(iii) On August 12, 2025, the Company and the holders of outstanding convertible promissory notes in an aggregate amount of approximately $1.8 million have agreed to extend to February 15, 2026 the maturity date of the Convertible Notes (the “New Maturity Date”), freeze the continuing accrual of interest and to not exercise their right to convert the Convertible Notes through the New Maturity Date, in consideration of the repayment in cash by the New Maturity Date of the outstanding principal and accrued interest on the Notes together with a premium not exceeding 10%. …”see in full comparison
Full comparison: every changed paragraph (38)
Severance pay
Certain of the Company’s
employees have subscribed to Section 14 of Israel’s Severance Pay Law, 5723-1963 (“Section 14”). According to this section,
these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies.
Payments in accordance with section 14 release the Company from any future severance liabilities (under the above Israeli Severance Pay
Law) in respect of those employees. Neither severance pay liability nor severance pay fund under Section 14 is recorded on the Company’s
balance sheet.
Identifiable intangible assets are stated at cost, net of accumulated amortization. Patents are amortized using the straight-line method over 7 years. Intellectual Properties are amortized using the straight-line method over its estimated useful economic life, as determined by the Company.
In addition, the Company capitalizes qualifying costs
incurred during the application development stage related to software developed for internal use. These costs are capitalized based on
qualifying criteria. Costs incurred to develop software applications consist of directly attributable costs of preparing the asset for
its intended use such as direct labor costs, direct consultants and subcontractors costs, and overhead. Testing of impairment is performed
annually over the period of the development project. The company the amortize those costs over 3 -5 years, using straight line method,
per the technology life period.
Capitalized internal-use software costs are included in intangibles assets, net in the consolidated statement of financial position. As of December 31, 2024, the Company didn’t amortize the internal-use software costs because it didn’t reach the necessary stage. During 2025, the Company reassessed the qualifying criteria for capitalizing development costs and, as a result, determined to amortize all costs that had previously been capitalized under this framework.
Significant Events that Occurred During 2025
(i) On each of July 24 and July 30, 2025, entities controlled by Mr. Yakir Abadi and Mr. Eldar Grady, the new CEO and Chairman of the Board, who were appointed to these positions as of August 12, 2025, invested 234,000 NIS in the Company by the purchase of units comprised if i) shares of the Company’s common stock, and: 2) warrants to purchase two (2) additional shares of common stocks exercisable through the second anniversary of the issuance of such options, at a per share exercise price of $0.01. The per unit purchase price was $0.005, for a total purchase price of 234,000 NIS (approximately $69,200 as of the date of this report).
(ii) On August 1, 2025, Mr. Asaf Porat and the Company reached an understanding that Mr. Porat’s position as the Chief Financial Officer has terminated. Mr. Porat continued to provide services to the Company through August 31, 2025. Effective August 12, 2025, Mr. Ron Mekler, who has served as a director of the Company through August 12, 205, was been appointed as Chief Financial Officer. Mr. Mekler resigned from his position as a director on the board on such date.
(iii) On August 12, 2025, the Company and the holders of outstanding convertible promissory notes in an aggregate amount of approximately $1.8 million have agreed to extend to February 15, 2026 the maturity date of the Convertible Notes (the “New Maturity Date”), freeze the continuing accrual of interest and to not exercise their right to convert the Convertible Notes through the New Maturity Date, in consideration of the repayment in cash by the New Maturity Date of the outstanding principal and accrued interest on the Notes together with a premium not exceeding 10%. The Company’s obligation to repay these amounts is subject to the Company raising additional operating capital. Thereafter, on December 31, 2025, the holders of outstanding convertible promissory notes of the Company in an aggregate amount of approximately $0.8 million have agreed to convert the outstanding balance of these notes into 263,411,477 shares of the Company’s Common stock (the “Conversion Shares”). In addition, the holder of convertible promissory notes of the Company in an aggregate amount $863,840 has agreed to (i) extend the maturity date of such notes by an additional two years to February 15, 2028 and (ii) to refrain from exercising the conversion of terms of such notes until the new extended maturity date. The interest on the balance of such note shall continue to accrue at per annum rate of eight percent (8%).
(iv) In consideration for its efforts in facilitating the extension of the maturity date of the Convertible Notes and the associated waivers discussed above, the Company agreed to issue to an unrelated third party consultant options for 45 million shares of Company common stock, which are vested upon grant and exercisable at a per share price of $0.0001, subject to a 12 month lockup.
(v) Subject to the increase in authorized share capital of the Company, the Company and each of Mr. Abadi and Mr. Grady (the “Share Capital Increase”) agreed that each of these individuals will be issued each options to purchase 638,961,306 shares of Company common stock, exercisable for a five year period and at the per share price, in each case as set forth below:
(vi) On September 30, 2025, the Board e agreed to change the aforementioned resolution regarding the issuance of such options to Mr. Abadi and Mr. Grady, and instead, to enter into a subscription agreement for an identical number of shares of the company’s common stocks at a per share purchase price of $0.0001. see Item (xi) below. The Subscription Agreement goes into effect upon the increase in the Company’s authorized share capital. The Subscription Agreement provides that if certain specified milestones are not achieved with five (5) years then all or part of the Subscription Shares are to be returned to Company’s treasury. In addition, under the Subscription Agreement, each of YA and EG are entitled to anti-dilution protection, such that in the event of any issuance by the Company of shares of Common Stock or securities convertible into shares of Common Stock, whether for cash, in exchange for assets, services, or pursuant to debt conversion or otherwise, the Company shall issue additional shares to YA and EG so that their respective percentage ownership shall be maintained following such issuance, provided that such anti-dilution protection shall be afforded for up to $7 million of value received by the Company, whether measured in gross proceeds, value of assets recorded on the Company’s financial statements or otherwise. Any adjustment shall be made at the end of each quarter following the release of the financial statements for the quarter in which the value was received.
Each of YA and EG received anti dilution protection. Such anti-dilution protection is intended to ensure that each of YA and EG maintains ownership of 17.5% of the Company’s fully diluted share capital, provided that such anti-dilution protection shall be afforded for up to $7 million of value received by the Company, whether measured in gross proceeds, value of assets recorded on the Company’s financial statements or otherwise.
(vii) On September 4, 2025, the Company accepted subscriptions for $550,000 from five qualified investors in consideration of the issuance, in the aggregate, of 45,333,333 shares of the Company’s common stock and warrants to purchase an additional 12,750,000 shares of common stock, exercisable for a period not exceeding 12 months and at per share exercise prices between $0.015 and $0.02.
(viii) On October 8, 2025, the Company accepted subscriptions for $50,000 from a qualified investor in consideration of the issuance, in the aggregate, of 2,000,000 shares of the Company’s common stock at per share prices between $0.019.
(ix) On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock. The total number of authorized shares of the Series B Preferred Stock is 100,000 shares.
On December 31 2025, an amendment was filed with the State of Nevada to the B Certificate of Designation providing that that each Series B Preferred Shares will automatically convert into 25,000 shares of Common Stock (the “Series B Mandatory Conversion”) upon the effectiveness of the Authorized Increase in Shares of Common Stock. On April 13, 2026, a further amendment was filed to correct a clerical error and providing that at the Series B Mandatory Conversion each Series B Preferred Share will convert into 50,000 shares of Common Stock.
(x) On December 29, 2025, the Company and its CFO, Ron Mekler, entered into a subscription agreement for the purchase by Mr. Mekler of 12,500,000 shares at a per unit purchase price of $0.018. RM also received warrant to purchase 12,500,000 shares of common stocks at an exercise price of $0.022. under the Subscription Agreement, RM is entitled to anti-dilution protection, such that in the event of any issuance by the Company of shares of Common Stock or securities convertible into shares of Common Stock, whether for cash, in exchange for assets, services, or pursuant to debt conversion or otherwise, the Company shall issue additional shares to RM so that his respective percentage ownership shall be maintained following such issuance, provided that such anti-dilution protection shall be afforded for up to $7 million of value received by the Company, whether measured in gross proceeds, value of assets recorded on the Company’s financial statements or otherwise. Any adjustment shall be made at the end of each quarter following the release of the financial statements for the quarter in which the value was received.
Mr. Mekler received anti dilution protection. Such anti-dilution protection is intended to ensure that RM maintains ownership of 2% of the Company’s fully diluted share capital, provided that such anti-dilution protection shall be afforded for up to $7 million of value received by the Company, whether measured in gross proceeds, value of assets recorded on the Company’s financial statements or otherwise. Any adjustment shall be made at the end of each quarter following the release of the financial statements for the quarter in which the value was received.
(xi) On December 31, 2025, AppYea completed its acquisition of its previously announced agreement with Techlott to purchase the Techlott Technology. Pursuant to the terms of the Purchase Agreement, the aggregate consideration to be paid by the Company (the “Consideration Shares”) of the Company’s Common Stock, representing 35% of the Company’s issued and outstanding capital on a fully diluted basis. However, pending the increase in the number of the authorized shares of the Company’s Common Stock (the “Authorized Common Stock Share Increase”), the Company issued to Techlott 35,684 shares of the newly created preferred stock, par value $0.0001 per share (the “Series B Preferred”), which by their terms automatically convert into the Consideration Shares upon the effectiveness of the Authorized Common Stock Share Increase.
Techlott received anti dilution protection. Such anti-dilution protection is intended to ensure that Techlott maintains ownership of 35% of the Company’s fully diluted share capital, provided that such anti-dilution protection shall be afforded for up to $10 million of value received by the Company, whether measured in gross proceeds, value of assets recorded on the Company’s financial statements or otherwise. Any adjustment shall be made at the end of each quarter following the release of the financial statements for the quarter in which the value was received.
(xii) On January 27, 2026, we accepted subscriptions for $750,000 from four qualified investors in consideration of the issuance, in the aggregate, of 34,090,908 shares of the Company’s common stock and, with respect to one investor for $450,000, warrants to purchase an additional 20,454,545 shares of common stock, exercisable for a period three years and at per share exercise price $0.026.
Revenues.
Revenues for
the twelve months ended December 31, 20242025 and 20232024 were $29,000$7,625 and $0$29,000 respectively. All revenues were attributable
to sales of our appnea devices.
Research
and Development Expenses,
Research and development expenses increaseddecreased from $124,000$339,000 for the year ended December 31, 20232024 to $339,000 $240,000
for the twelve months ended
December 31, 2024.2025. The increasedecrease is primarily attributable to increasedreduced outlaysdevelopment inactivities respectassociated with
certain of the development of ourCompany’s products.
General
and Administrative
Expenses. General and administrative expenses decreasedincreased from $1,386,000$1,114,000 for the year ended December 31, 20232024 to $1,114,000
$16,689,000 for the
twelve months ended December 31, 2024.2025. The decreaseincrease in expenses is primarily attributableattribute able to lowerremeasurement salaryof expensesapproximately
$15.7 recordedmillion in the 2024fair period.value of contingent liability components and anti-dilution features related to the issuance of shares to controlling
shareholders.
$1,128,000 of the 2024 expenses
were non-cash stock-based compensation expenses resulting from options awards to our Chief Executive Officer and Chief Financial Officer
and advisors.
Loss.
Loss for the twelve
months ended December 31, 20242025 and 2023,2024, was $4,032,000$15,097,000 and $1,817,000$4,032,000 respectively and is primarily attributable
to remeasurement of approximately $9 million in the fair value of contingent liability components and anti-dilution features related
to the issuance of shares to controlling shareholders and to Change in fair value
of convertible loans and non-cash stock based compensation expenses referred to above.loans..
AppYea
has experienced operating
losses since its inception and had a total accumulated deficit of $10,358,000$25,455,000 as of December 31, 2024.2025. We expect
to incur additional costs
and require additional capital. We have incurred losses in nearly every year since inception. These losses
have resulted in significant
cash used in operations. During the years ended December 31 20242025 and 2023,2024, our cash used in operations was
approximately $785,000$606,000 and
$597,000, $785,000, respectively. We need to continue and amplify our research and development efforts for our product candidates (which are in
various stages of development), strengthen our patent portfolio, establish operations processes, pursue FDA clearance and international
regulatory approvals and invest in marketing of our products, as we continue to conduct these activities,
we expect the cash needed to
fund operations to increase significantly over the next several years.
Between January
December 2024 and
March December 2025, we raised an aggregate of $591,000$260,000 from private placement of shares of our common stock at a per share
price of $0.01 and
the issuance of warrants, exercisable for a two year period from the date of issuance for an identical number of shares
at a per share
exercise price of $0.04, and additional $125,000$124,000 from public capital raised through the company effective prospectus. In addition, $124,000
were raised from the exercise of outstanding warrants at an exercise price of $0.0066
per share, which was reduced from $0.04 if exercised within a $0.0066specified price.shorter duration. In respect of the raise the investors are entitled
to an aggregate 90,430,000
26,000,000 shares of our common stock and 71,643,100identical number of warrants, of which 59,143,10013,500,000 have already been issued.
The subscription proceeds are being
used to complete the IOS design and development of our biofeedback snoring treatment wristband (AppySleep
product) as well as general
corporate matters. More recently, we raised in July 2025 through entities controlled by Mr. Yakir Abadi and
Mr. Eldad Grady, the new CEO and Chairman of the Board, respectively, appointed as of August 12, 2025, invested 234,000 NIS in the Company
by the purchase of units comprised of; 1) Shares of the Company’s common stock at a par value of $0.0001 per share, and: 2) Warrants
to purchase two (2) additional shares of common stocks exercisable through the second anniversary of the issuance of such options, at
a per share exercise price of $0.01, at a per unit purchase price of $0.005 for a total purchase price of 234,000 NIS (approximately
$69,200 as of the date of this report). Each of them received 7,000,000 of Company’s shares of common stock.
On September 4, 2025, the Company accepted subscriptions for $550,000 from five qualified investors in consideration of the issuance, in the aggregate, of 45,333,333 shares of the Company’s common stock and warrants to purchase an additional 12,750,000 shares of common stock, exercisable for a period not exceeding 12 months and at per share exercise prices between $0.015 and $0.02.
On October 8, 2025, the Company accepted subscriptions for $50,000 from a qualified investor in consideration of the issuance, in the aggregate, of 2,000,000 shares of the Company’s common stock prices between $0.019.
As of January 27, 2026, we accepted subscriptions for $750,000 from four qualified investors in consideration of the issuance, in the aggregate, of 34,090,908 shares of the Company’s common stock and, with respect to one investor for $450,000, warrants to purchase an additional 20,454,545 shares of common stock, exercisable for a period three years and at per share exercise price $0.026.
On December 31, 2025, the holders of outstanding convertible promissory notes of the Company in an aggregate amount of approximately $0.8 million have agreed to convert the outstanding balance of these notes into 263,411,477 shares of the Company’s Common stock (the “Conversion Shares”). In addition, the holder of convertible promissory notes of the Company in an aggregate amount $863,840 has agreed to (i) extend the maturity date of such notes by an additional two years to February 15, 2028 and (ii) to refrain from exercising the conversion of terms of such notes until the new extended maturity date. The interest on the balance of such note shall continue to accrue at per annum rate of eight percent (8%).
Management
believes that
funds on handhand, will enable us to fund our operations and capital expenditure requirements through theDecember end of the second quarter of
2025.2026. We need
to raise additional operating capital in order to maintain operations as presently conducted and to realize our
business plan.plan Webeyond
such cannot be sure that future funding will be available to us on acceptable terms, or at all. Due to often volatile
nature of the financial markets, equity and debt financing may be difficult to obtain.date.
Our accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these consolidated financial statements. However, the Company has incurred substantial losses. Our current liabilities exceed our current assets and available cash is not sufficient to fund the expected future operations. The Company is raising additional capital through debt and equity securities in order to continue the funding of its operations. However, there is no assurance that the Company can raise enough funds or generate sufficient revenues to pay its obligations as they become due, which raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying value of assets or liabilities as a result of this uncertainty.
We cannot be sure that future funding will be available to us on acceptable terms, or at all. Due to often volatile nature of the financial markets, equity and debt financing may be difficult to obtain.
We will need to obtain additional funding in order to pursue our business
plans. We may seek to raise any necessary
additional capital through a combination of private or public equity offerings, debt financings, collaborations,
strategic alliances,
licensing arrangements and other marketing and distribution arrangements. To the extent that we raise additional
capital through marketing
and distribution arrangements or other collaborations, strategic alliances or licensing arrangements with third
parties, we may have to
relinquish valuable rights, future revenue streams, or product candidates or to grant licenses on terms that
may not be favorable to us.
If we raise additional capital through private or public equity offerings, the ownership interest of our
existing stockholders will be
diluted, and the terms of these securities may include liquidation or other preferences that adversely
affect our stockholders’
rights. If we raise additional capital through debt financing, we may be subject to covenants limiting
or restricting our ability to take
specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.
For
the year ended December
31, 2024,2025, and as of the date of this report, we assessed our financial condition and concluded that based on
our current and projected
cash resources and commitments, as well as other factors mentioned above, there is a substantial doubt
about our ability to continue
as a going concern. Our financial statements have been prepared assuming that we will continue as a
going concern and, accordingly, do
not include adjustments relating to the recoverability and realization of assets and
classification of liabilities that might be necessary
should we be unable to continue in operation. We have a stockholders’accumulated deficit of $4,128,000$25,455,000 and a working capital deficit of $1,535,000
$224,000 on December
31 2024,2025, as well as negative operating cash flows. Our report from our independent registered public accounting firm for
the year
ended December 31, 2024,2025, includes an explanatory paragraph stating the Company has recurring losses and limited operations which
raise substantial doubt about its ability to continue as a going concern. If the Company is unable to obtain adequate capital, the
Company Company
may be required to reduce the scope, delay, or eliminate some or all of its planned operations. These factors, among others,
raise substantial
doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the
carrying value of assets
or liabilities as a result of this uncertainty.
What changed in the latest 10-Q
Risk Factors
An investment in our common stock involves a high degree of risk. There have been no material changes to the risk factors disclosed under Item 1A of the 2025 10-K. Investors should carefully consider those risk factors, in addition to the other information contained in this Quarterly Report on Form 10-Q and our other reports filed with the SEC, before purchasing or otherwise acquiring shares of our common stock. The risks and uncertainties described in those filings are not the only ones we face. Additional risks and uncertainties not currently known to us, or that we currently consider immaterial, may also impair our business operations.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Removed heading “January 2026 Capital Raise.”
Largest changes
Comparison of the Three and Six Months Endedsee in full comparisonMarchJune31,30, 2026 to the Three and Six Months EndedMarchJune31,30, 2025
General and administrative expenses for the three and six months endedsee in full comparisonMarchJune31,30, 2026 were approximately$413,000,$496,000 and $915,000, respectively, compared to$111,000$97,000 and $208,000 for the three and six months endedMarchJune31,30,2025.2025, respectively. The increase reflects, among other items, the following developments that occurred afterMarchJune31,30, 2025 and are present for the first full quarterly period in thethreesix months endedMarchJune31,30, 2026: (i) monthly consulting fees payable to the senior management team appointed in August 2025 (Mr. Abadi, Mr. Grady, and Mr. Mekler) and December 2025 (Mr. Katzenelson and Mr. Ben Harris), aggregating approximately$255,000$140,000ofper month in basemonthlyfeesfor the period(calculated as base monthly fees of $30,000 per month for each of Mr. Abadi, Mr. Grady, Mr. Katzenelson, Mr. Harris, and $10,000 per month for both Mr.Mekler,MeklerforandtheMr. Boris Molchadsky) of which due to cashflow constrains only $7,000 per month are inthreefactmonthspaidended March 31, 2026)out; (ii) share-based non-cash compensation expense relating to options granted to officers and consultants (including $78,000$78,000and $81,000 of expense related to the vesting of7,500,00015,000,000 options held by Mr. Mekler on March31,312026and June 30, 2026, respectively), as compared to a net credit to share-based compensation in the prior period; and (iii) professional fees relating to the Company’s public reporting program, the Techlott IP acquisition, and ongoing legal matters. None of the professional fees to our management team have in fact been paid due to cash flow constraints but such amounts are being accrued, except for a monthly fee of $7,000 (of the $10,000) being paid to the Company’s CFO.
Research and development expenses for the three and six months endedsee in full comparisonMarchJune31,30, 2026 were approximately$215,000,$225,000 and $434,000, respectively, compared toa$221,000netandcredit$215,000of $(6,000)for the three and six months endedMarchJune31,30,2025.2025, respectively. Research and Development expenses for theperiodthree and six months ended June 30, 2026 primarily consisted of approximately $90,000 and $164,000, respectively, in respect$63,000of development costs associated with the continued enhancement and deployment of the acquired lottery platform, as well as $135,000$135,000and $270,000, respectively, of allocated compensation expenses relating to the Company’s CTO (Ben Harris) and certain members of management that were previously attributed to research and development activities. Mr. Harris was appointed on December 31, 2025 and is entitled to monthly compensation of $30,000.The prior-period net credit reflected the reversal of previously recognized share-based compensation expense in connection with the forfeiture of stock options held by the Company’s former Chief Executive Officer, in January 2025; cash research and development expenses in the prior period were significantly lower than in the current period as a result of reduced engineering staffing during the strategic transition.
“Cash and cash equivalents available to the Company increased substantially during the year ended December 31, 2025 (from $79,000 at December 31, 2024 to $408,000 at December 31, 2025) in connection with the strategic pivot and related capital raising activities described in the 2025 10-K. …”see in full comparison
Thesee in full comparisonthreesix months endedMarchJune31,30, 2026 represent the firstfullsixquartermonths following the Company’s strategic pivot to blockchain-basedblockchain-basedlottery technology and the consummation of the Techlott IP acquisition on December 31, 2025. Thethreesix months endedMarch 31,June 30, 2025 reflect the Company’s operations as a digital healthcompany under prior senior management, prior to the engagement of the current Chief Executive Officer (Yakir Abadi), Executive Chairman (Eldar Edmond Grady), and Chief Financial Officer (Ron Mekler) in August 2025, and prior to the engagement of the current President (Mark Katzenelson) and Chief Technology Officer (Ben Harris) in December 2025. Period-over-period comparability is therefore materially limited.company.
Full comparison: every changed paragraph (30)
Forward-looking
statements rest on management’s current expectations and are subject to substantial risks, uncertainties, and changes in circumstances
that are outside the Company’s control. Actual results may differ materially. Important factors are described under the heading
“Risk Factors” in our 2025 10-K, as updated by our subsequent filings with the SEC. Except as required by law, we undertake
no obligation to update or revise any forward-looking statement to reflect events or circumstances arising after the date of this report.
The terms “we,” “us,” “our,” “AppYea,Techlott,” and the “Company” refer to AppYea,Techlott,
Inc. and its consolidated subsidiaries unless context otherwise requires.
We
are a Nevada corporation whose common stock is quoted on the OTC Markets, OTCQB tier, under the symbol “APYP.LOTT.” We currently
operate in two areas: (i) the development and commercial deployment of a blockchain-based technology platform supporting licensed lottery,
draw-based gaming, and casino-style gaming operators, which is our principal area of focus following our acquisition of the Techlott
IP on December 31, 2025;
and (ii) legacy digital health products developed by our wholly-owned subsidiary SleepX for sleep apnea and
snoring monitoring, with
respect to which we continue to evaluate strategic options.
Our
blockchain-based technology is designed to support core lottery operational processes — including ticket registration, draw execution,
and prize distribution — through smart-contract logic, verifiable randomness, and audit-trail capabilities intended to support
regulatory and operator-side compliance. As of the date of this report, our commercial operations consist of one active customer deployment,
located in The Gambia. All of our material commercial revenue from the platform during the three months ended March 31, 2026 was derived
from this single customer. While our existing commercial deployment is in the lottery vertical, the Platform’s underlying components,
including smart-contract execution, verifiable randomness, and modular backend services, are configurable to support a broader range
of of
regulated gaming applications, including casino-style table games and instant-win products, when offered by licensed gaming operators
in jurisdictions where such activities are permitted. Casino and other gaming operations are typically subject to distinct licensing
regimes regimes
and regulatory requirements that differ materially from those applicable to lottery operations, and operators offering such products
would would
generally be required to hold the relevant gaming licenses and to comply with the regulatory requirements applicable in their respective
jurisdictions.
We have developed and commercially deployed a technology platform designed to support lottery and gaming operations through a combination of smart contract infrastructure, verifiable randomness, and modular backend systems. The Platform is intended to support transparency, operational efficiency, and auditability for lottery and gaming operators and regulators. The Platform is designed to be deployed alongside, or as a replacement for, an operator’s existing legacy systems, depending on operator requirements; we do not represent that the Platform alone ensures operational efficiency or regulatory compliance, both of which depend on the operator’s broader system architecture, business processes, and regulatory environment.
As
of the date of this report, our commercial operations are in an early stage, with one active customer deployment in The Gambia, Africa.
AllWe ofintend to generate our lottery and gamingfirst revenue to date has been derived from this singleclient customer.during the third quarter of 2026. Our future growth depends on, among other things,
securing additional customers, expanding into new markets, and continuing to develop the Platform.
Key
Financial Terms and Metrics
We
have generated insignificant revenues from product sales to date.
The
process of researchingDeveloping and developingenhancing our producttechnology candidatesplatform is lengthy,an unpredictable,ongoing andprocess that is subject to manytechnical risks.and commercial
uncertainty. We expect to continue
incurring substantial expenses for the next several years as we continue to develop ourthe product candidates.platform. We are unable, with any certainty,
to estimate
either the costs or the timelines in which those expenses will be incurred. The design andContinued development of ourthe devicesplatform will
consume a large
proportion of our current, as well as projected, resources.
Financial
expenses consist primarily of the impact of exchange rate derived from re-measurement of monetary balance sheet items denominated in
non-dollar currencies. Other financial expenses include bank’sbank fees and interest on long term loans. Financial income derives mainly
mainly from change in derivative value of convertible loans.
Comparison
of the Three and Six Months Ended MarchJune 31,30, 2026 to the Three and Six Months Ended MarchJune 31,30, 2025
The
three six months ended MarchJune 31,30, 2026 represent the first fullsix quartermonths following the Company’s strategic pivot to
blockchain-based blockchain-based
lottery technology and the consummation of the Techlott IP acquisition on December 31, 2025. The threesix months ended March 31,June
30, 2025 reflect
the Company’s operations as a digital health company under prior senior management, prior to the engagement of the current Chief
Executive Officer (Yakir Abadi), Executive Chairman (Eldar Edmond Grady), and Chief Financial Officer (Ron Mekler) in August 2025, and
prior to the engagement of the current President (Mark Katzenelson) and Chief Technology Officer (Ben Harris) in December 2025. Period-over-period
comparability is therefore materially limited.company.
The
Company did not generate any revenue for the three monthsand six month periods ended MarchJune 31,30, 2026, compared to $3,000$1,000 and $4,000 for the
three threeand six months ended MarchJune 31,30, 2025.
Prior-period revenue was attributable to legacy sales of the SleepX AppySleep biofeedback
wristband and related products.
The
Company did not incur cost of sales for the three and six months ended MarchJune 31,30, 2026, compared to $4,000 and $8,000 for the three
and six months ended MarchJune 31,
30, 2025. The change reflects the shift in revenue mix from physical product sales (SleepX) to
platform-based services (Techlott IP).
Research
and development expenses for the three and six months ended MarchJune 31,30, 2026 were approximately $215,000,$225,000 and $434,000, respectively,
compared to a$221,000 netand credit$215,000 of $(6,000)
for the three and six months ended MarchJune 31,30, 2025.2025, respectively. Research and Development expenses
for the periodthree and six months ended June 30, 2026 primarily consisted of approximately $90,000 and $164,000, respectively, in respect
$63,000 of development costs associated with the continued enhancement and deployment of the acquired lottery platform, as well as $135,000
$135,000and $270,000, respectively, of allocated compensation expenses relating to the Company’s CTO (Ben Harris) and certain members
of management that were
previously attributed to research and development activities. Mr. Harris was appointed on December 31, 2025
and is entitled to
monthly compensation of $30,000. The prior-period net credit reflected the reversal of previously recognized share-based
compensation expense in connection with the forfeiture of stock options held by the Company’s former Chief Executive Officer,
in January 2025; cash research and development expenses in the prior period were significantly lower than in the current period as a
result of reduced engineering staffing during the strategic transition.
The prior-period research and development expenses were primarily attributed to write-offs of certain investments in intellectual property and development of our products.
Amortization expenses for the three and six months ended June 30, 2026 were approximately $534,000 and $1,067,000, respectively, compared to nil for the three and six months ended June 30, 2025.
AmortizationFor
expenses for the three and six months ended MarchJune 31,30, 2026 were2026, approximately $533,000,$528,000 comparedand to nil for the three months ended March 31,
2025. Approximately $528,000$1,056,000 of the amortization expensesexpenses, relatesrespectively, related to the intellectual property acquired from Techlott on December 31,
2025, with the remaining amount attributable to the amortization
of legacy SleepX patent assets.
Sales
and marketing expenses for the three and six months ended MarchJune 31,30, 20262026, respectively, were approximately $23,000,$52,000 and $75,000, compared
to $17,000$32,000 and $49,000 for the three and six months
ended MarchJune 31,30, 2025.2025, respectively.
General
and administrative expenses for the three and six months ended MarchJune 31,30, 2026 were approximately $413,000,$496,000 and $915,000, respectively,
compared to $111,000$97,000 and $208,000 for the
three and six months ended MarchJune 31,30, 2025.2025, respectively. The increase reflects, among other
items, the following developments that occurred
after MarchJune 31,30, 2025 and are present for the first full quarterly period in the three six
months ended MarchJune 31,30, 2026: (i) monthly consulting fees
payable to the senior management team appointed in August 2025 (Mr. Abadi,
Mr. Grady, and Mr. Mekler) and December 2025 (Mr.
Katzenelson and Mr. Ben Harris), aggregating approximately $255,000$140,000 ofper month in
base monthly fees for the period (calculated as base monthly fees
of $30,000 per month for each of Mr. Abadi, Mr. Grady, Mr. Katzenelson, Mr. Harris, and
$10,000 per month for both Mr. Mekler,Mekler forand theMr. Boris Molchadsky) of which due to cashflow constrains only $7,000 per month are in
threefact monthspaid ended March 31, 2026)out; (ii) share-based non-cash compensation expense relating to options granted to officers and consultants
(including
$78,000 $78,000and $81,000 of expense related to the vesting of 7,500,00015,000,000 options held by Mr. Mekler on March 31,31 2026and June 30, 2026,
respectively), as compared to a net
credit to share-based compensation in the prior period; and (iii) professional fees relating to the Company’s public reporting
program, the Techlott IP acquisition,
and ongoing legal matters. None of the professional fees to our management team have in fact been paid due to cash flow constraints
but such amounts are being accrued, except for a monthly fee of $7,000 (of the $10,000) being paid to the Company’s
CFO.
The
change in fair value of convertible loans and derivative liabilities for the three months ended March 31, 2026 was expense of approximately
$386,000, compared to expense of $(44,000)recorded for the three and six months ended MarchJune 31,30, 2026 were approximately $556,000 and $942,000, respectively, compared to income of $358,000 and $314,000 for the three and six
months ended June 30, 2025. The current-period amount reflects the remeasurement
of (i) the Plutus Note carried at fair value
pursuant to the fair value option under ASC 815 and (ii) the anti-dilution derivative liabilities
recognized in December 2025 in
connection with the Techlott IP acquisition and the contractual anti-dilution rights of senior management.
The prior-period amount
reflected the remeasurement of convertible loan instruments outstanding during that period, none of which remain
outstanding as of
June March 31,30, 2026 (other than the Plutus Note).
Financial
income (expenses), net for the three and six months ended MarchJune 31,30, 2026 waswere incomeexpenses of approximately $2,000,$6,000 and $4,000, respectively,
compared to expense of $1,000$11,000 and $10,000 for
the three and six months ended MarchJune 31,30, 2025.2025, respectively. Financial income for the period was primarily
attributable to interest earned on U.S. dollar-denominated
deposits. Financial expenses primarily reflect interest accrual on outstanding
debt obligations and the effect of remeasurement of monetary
balances denominated in non-U.S. dollar currencies (principally the New
Israeli Shekel).
Net
loss for the three and six months ended MarchJune 31,30, 2026 waswere approximately $(1,568,0001,869,000) and $(3,437,000), compared to net loss of $(166,0006,000)
and $(172,000) for the three and six months
ended MarchJune 31,30, 2025.2025, respectively. The increase in net loss primarily reflects the items
described above, in particular the post-acquisition amortization
of the Techlott IP and the consulting fees payable to the senior management
team appointed during the second half of 2025.
We
have funded our operations to date through a combination of equity issuances and convertible debt financings. As of MarchJune 31,30, 2026, we
had cash and cash equivalents of approximately $811,000$495,000 and total liabilities of approximately $9,726,000,$10,663,000, of which approximately $8,848,000$9,715,000
were current. As of December 31, 2025, we had cash and cash equivalents of $408,000.
Cash
and cash equivalents available to the Company increased substantially during the year ended December 31, 2025 (from $79,000 at December
31, 2024 to $408,000 at December 31, 2025) in connection with the strategic pivot and related capital raising activities described in
the 2025 10-K. The Company’s reported operating cash usage for the three months ended March 31, 2026 reflects materially higher
fixed operating costs than for the corresponding 2025 period, attributable principally to the consulting arrangements with the senior
management team that took effect in August 2025 and December 2025.
January
2026 Capital Raise.
On
January 27, 2026, we received aggregate proceeds of $750,000 from four qualified investors, in exchange for the issuance of 34,090,910
shares of common stock and warrants to purchase up to 20,454,545 additional shares of common stock at an exercise price of $0.026 per
share, exercisable for a three-year period. The proceeds are being used for general corporate purposes, including the continued development
of our blockchain-based technology platform.
For
the threesix months ended MarchJune 31,30, 2026, and as of the date of this report, we assessed our financial condition and concluded that
based on
our current and projected cash resources and commitments, as well as other factors mentioned above, there is a substantial
doubt about
our ability to continue as a going concern. Our financial statements have been prepared assuming that we will continue
as a going concern
and, accordingly, do not include adjustments relating to the recoverability and realization of assets and
classification of liabilities
that might be necessary should we be unable to continue in operation. We have an accumulated deficit
of $27,023,000$28,892,000 and a working capital
deficit of $7,934,000$9,119,000 on MarchJune 31,30, 2026, as well as negative operating cash flows. Included in
this amount is a non-monetary liability
of approximately $7,837,000$8,320,000 related to anti-dilution obligations reflecting the future
potential issuance of shares to investors and
controlling shareholders in connection with future equity issuances. Excluding this
non-monetary component, the Company’s working
capital deficit would have been approximately $97,000.$799,000.
We cannot be sure that future funding will be available to us on acceptable terms, or at all. Due to the often volatile nature of the financial markets, equity and debt financing may be difficult to obtain.
We
may seek to raise any necessary additional capital through a combination of private or public equity offerings, debt financings, collaborations,
strategic alliances, licensing arrangements and other marketing and distribution arrangements. To the extent that we raise additional
capital through marketing and distribution arrangements or other collaborations, strategic alliances or licensing arrangements with third
parties, we may have to relinquish valuable rights, future revenue streams, or product candidatestechnologies or to grant licenses on terms that
may not be favorable to us. If we raise additional capital through private or public equity offerings, the ownership interest of our
existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely
affect our stockholders’ rights. If we raise additional capital through debt financing, we may be subject to covenants limiting
or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.
Our
critical accounting estimates are described in the 2025 10-K. Critical estimates affecting the unaudited condensed consolidated financial
statements for the three and six months ended MarchJune 31,30, 2026 include, in particular, (i) the fair value of the Plutus Note (Level 3 inputs);
(ii)
the fair value of derivative liabilities relating to anti-dilution rights (Level 3 inputs); (iii) the recoverability and useful life
life of the Techlott IP intangible asset; and (iv) the going-concern assessment. Changes in the assumptions or unobservable inputs underlying
these estimates could have a material effect on our reported results.
LOTT insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding LOTT (13F)
None of the 59 investors we track reported a position in their latest 13F.